An open-label, randomized, two treatment, cross over, single dose study to determine the effect of food on the pharmacokinetics of a fixed dose combination of aliskiren (SPP100)/ amlodipine/ hydrochlorothiazide 300/10/25 mg tablet in healthy subjects under fasted and fed condition

Trial Profile

An open-label, randomized, two treatment, cross over, single dose study to determine the effect of food on the pharmacokinetics of a fixed dose combination of aliskiren (SPP100)/ amlodipine/ hydrochlorothiazide 300/10/25 mg tablet in healthy subjects under fasted and fed condition

Recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top